Less than a week after issuing sweeping ruling that bars most lawsuits against medical device makers, the Supreme Court heard arguments in the first of two cases that could determine whether drug makers receive similar protection. The fundamental question in these cases is who should make the decisions that will determine whether a drug is "on balance, going to save people, or on balance, going to hurt people?" A jury of 12 is would be more likely to see before them only the people whom the drug hurt and don't see the many more who need the drug to cure them. Conservatives are much more likely than liberals to unnerstand this position. This would severely limit the billions of dollars taken by the trial lawyers in such lawsuits. Bills to limit lawsuits, or tort reform, are routinely voted no my Democrats and yes by Republicans due to the fact that the Trial Lawyers Assn. of America gives 97% of their political donations to the Democratic party. You don't bite the hand that feeds you.
Justice Stephen Breyer sez "congress left policing of the medicine market exclusively to the Food and Drug Administration." The FDA completely oversees the drug and device markets, and should no be second-guessed by courts
I report,U decide.
No comments:
Post a Comment